Replimune Group, Inc.

NasdaqGS:REPL Stock Report

Market Cap: US$912.4m

Replimune Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:REPL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Nov 24SellUS$56,131Christopher SarchiIndividual5,207US$10.78
18 Nov 24SellUS$78,112Konstantinos XynosIndividual7,246US$10.78
16 Aug 24SellUS$90,989Emily HillIndividual8,938US$10.18
16 May 24SellUS$130,655Sushil PatelIndividual20,194US$6.47
16 May 24SellUS$245,394Philip Astley-SparkeIndividual37,928US$6.47
16 May 24SellUS$113,969Colin LoveIndividual17,615US$6.47
16 May 24SellUS$14,868Andrew SchwendenmanIndividual2,298US$6.47
16 May 24SellUS$41,194Konstantinos XynosIndividual6,367US$6.47
16 May 24SellUS$74,172Robert CoffinIndividual11,464US$6.47
16 May 24SellUS$14,350Christopher SarchiIndividual2,218US$6.47

Insider Trading Volume

Insider Buying: REPL insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of REPL?
Owner TypeNumber of SharesOwnership Percentage
General Public764,5921.01%
Individual Insiders4,130,4405.48%
VC/PE Firms4,866,4496.46%
Hedge Funds15,826,51921%
Institutions49,752,44466%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.6%.

Top Shareholders

Top 25 shareholders own 84.83% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.7%
Baker Bros. Advisors LP
11,045,336US$133.8m9.95%1.37%
13.1%
T. Rowe Price Group, Inc.
9,879,250US$119.6m6.96%0.01%
7.26%
BlackRock, Inc.
5,471,564US$66.3m16.1%no data
6.46%
Forbion Capital Partners B.V.
4,866,449US$58.9m0%10.3%
6.35%
Redmile Group, LLC
4,781,183US$57.9m-14%3.45%
4.6%
The Vanguard Group, Inc.
3,466,247US$42.0m19.7%no data
4.08%
Braidwell LP
3,070,837US$37.2m203%1.73%
3.27%
Omega Fund Management, LLC
2,461,319US$29.8m0%16.33%
3.11%
State Street Global Advisors, Inc.
2,340,042US$28.3m102%no data
2.33%
Robert Coffin
1,755,779US$21.3m0%no data
2.05%
Morgan Stanley, Investment Banking and Brokerage Investments
1,542,884US$18.7m-2.72%no data
2.04%
Tavistock Life Sciences
1,536,341US$18.6m0%1.35%
1.9%
Geode Capital Management, LLC
1,428,301US$17.3m17.9%no data
1.69%
Philip Astley-Sparke
1,274,421US$15.4m-3.78%no data
1.59%
Tang Capital Management, LLC
1,200,000US$14.5m49%1.1%
1.53%
Millennium Management LLC
1,154,821US$14.0m-63%0.01%
1.5%
RTW Investments, LP
1,133,787US$13.7m0%0.21%
1.15%
D. E. Shaw & Co., L.P.
867,683US$10.5m-6.88%0.01%
1.13%
EcoR1 Capital, LLC
850,341US$10.3m0%0.37%
1.01%
Parkman Healthcare Partners LLC
763,747US$9.2m45.5%1.32%
0.96%
Colin Love
724,399US$8.8m0%no data
0.83%
FMR LLC
626,412US$7.6m-16.2%no data
0.76%
Schonfeld Strategic Advisors LLC
572,227US$6.9m-41.7%0.06%
0.73%
Northern Trust Global Investments
549,501US$6.7m18.6%no data
0.72%
Dimensional Fund Advisors LP
545,341US$6.6m-10.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 23:31
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Replimune Group, Inc. is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter LawsonBarclays
Clarence PowellBMO Capital Markets Equity Research
Evan SeigermanBMO Capital Markets Equity Research